Ranier's Compounding Laboratory is recalling various 0.03% Tacrolimus and 1% Cyclosporine ophthalmic (eye) drops because manufacturing practices at the firm may have compromised the sterility of the products. Approximately 25 units were distributed, which are intended to be sterile; however, a potential contamination risk exists that could lead to serious eye infections. These prescription medications were dispensed in 5 mL and 10 mL droptainers exclusively in Pennsylvania.
The use of contaminated eye drops poses a risk of serious eye infections, which can lead to vision loss or other severe health complications. While no specific incidents have been reported, the firm's practices were found to pose a significant risk to the sterile environment required for these medications.
Pharmaceutical refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response